title: Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
abstract: The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. This guideline for the treatment of segmental and nonsegmental vitiligo has been developed by the members of the Vitiligo European Task Force and other colleagues. It summarizes evidence-based and expert-based recommendations (S1 level).
authors.affiliation: Service de Dermatologie, CHU de Bordeaux, Bordeaux Cedex, France.
authors.forename: A
authors.initials: A
authors.lastname: Taieb
authors.forename: A
authors.initials: A
authors.lastname: Alomar
authors.forename: M
authors.initials: M
authors.lastname: Böhm
authors.forename: M L
authors.initials: ML
authors.lastname: Dell'anna
authors.forename: A
authors.initials: A
authors.lastname: De Pase
authors.forename: V
authors.initials: V
authors.lastname: Eleftheriadou
authors.forename: K
authors.initials: K
authors.lastname: Ezzedine
authors.forename: Y
authors.initials: Y
authors.lastname: Gauthier
authors.forename: D J
authors.initials: DJ
authors.lastname: Gawkrodger
authors.forename: T
authors.initials: T
authors.lastname: Jouary
authors.forename: G
authors.initials: G
authors.lastname: Leone
authors.forename: S
authors.initials: S
authors.lastname: Moretti
authors.forename: L
authors.initials: L
authors.lastname: Nieuweboer-Krobotova
authors.forename: M J
authors.initials: MJ
authors.lastname: Olsson
authors.forename: D
authors.initials: D
authors.lastname: Parsad
authors.forename: T
authors.initials: T
authors.lastname: Passeron
authors.forename: A
authors.initials: A
authors.lastname: Tanew
authors.forename: W
authors.initials: W
authors.lastname: van der Veen
authors.forename: N
authors.initials: N
authors.lastname: van Geel
authors.forename: M
authors.initials: M
authors.lastname: Whitton
authors.forename: A
authors.initials: A
authors.lastname: Wolkerstorfer
authors.forename: M
authors.initials: M
authors.lastname: Picardo
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000975:Antioxidants / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D057189:Checklist; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D062327:Skin Lightening Preparations / Q000627:therapeutic use; D013256:Steroids / Q000008:administration & dosage; D016896:Treatment Outcome; D014820:Vitiligo / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000975:Antioxidants; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D062327:Skin Lightening Preparations; D013256:Steroids